New Vision Eye Clinic

Shanghai Xima Ruishi Eye Hospital, the former Shanghai Ruijin Hospital Eye Center is affiliated to the listed medical institution-Xima International Eye Medical Group. Xima International Eye Medical Group (abbreviation: Xima Eye) is a large An ophthalmology chain institution, a Hong Kong IPO listed medical institution (stock code: 03309), was established in January 2012, headquartered in Hong Kong, China, with Lin Shunchao Eye Centers in Central, Kowloon, Mong Kok, Shatin, Causeway Bay, and Kwun Tong. There are also Shenzhen Simalin Shunchao Eye Hospital, Shenzhen Xin'an Simalin Shunchao Eye Hospital, Beijing Simalin Shunchao Eye Hospital, Shanghai Eye Hospital, and Shanghai Simarishi Eye Hospital. Shanghai Cima Ruishi Eye Hospital is one of the domestic priority hospitals for excimer laser myopia surgery. It has now developed into a professional ophthalmology medical group integrating myopia laser, fundus disease diagnosis and treatment, phacoemulsification minimally invasive surgery and medical optometry , And won the titles of refractive superior specialty and four-star medical institution, "Shanghai Care for the Next Generation Research Center" Juvenile Eye Disease Prevention and Control Base, and Harmonious Enterprise Model Unit. The headquarters of the hospital is located in the core area of ​​Huangpu District. The Putuo, Pudong and Yangpu branches cover the central area of ​​Shanghai with convenient transportation. More than 20 years of glorious history, from Lasik surgery to personalized comprehensive vision quality improvement solutions, providing eye health services for all ages, customized diagnosis and treatment plans for different groups of people, and multiple payment methods such as domestic medical insurance and overseas insurance payment , Aims to create a professional, safe, easy and humanized medical service model. In order to maintain the quality of diagnosis and treatment in line with international standards, we also regularly carry out various forms of internal training, led by the dean, Professor Lin Shunchao, including well-known experts hired by Xima Ophthalmology. According to the plan, we regularly organize clinicians in the hospital to study and discuss cutting-edge industry Diagnosis and treatment technology and philosophy. In addition, by organizing or co-organizing large-scale ophthalmology academic conferences, doctors and trainees are provided with an important platform for grasping new developments in the field of ophthalmology. We firmly believe that "only good scientific research can bring new hope to patients, and only continuous innovation in research can make Chinese ophthalmology a foothold in the world." Xima ophthalmology clinical education and subject research, published in core medical journals at all levels A large number of articles, more than 1,000 SCI papers. Especially in children with congenital cataracts, strabismus, and acute traumatic intractable eye diseases, the treatment technology is at a relatively advanced level.